Effect Of The Use Of Navigation In The Alignment Obtained When Performing A Total Knee Arthroplasty In Obese Patients

November 27, 2023 updated by: Pedro-José Torrijos-Garrido
NAOBE is a randomized, open and prospective clinical trial that evaluates the accuracy to achieve an adequate mechanical axis of the lower extremity in obese patients after total knee replacement.

Study Overview

Detailed Description

Randomized, open and prospective clinical trial.

Following the surgical indication for a total knee replacement as treatment for symptomatic osteoarthritis and the confirmation of obesity (BMI equal or greater than 30 Kg/m2 ), patients will be randomly assigned (ratio 1:1) to one of the following treatments:

Control group: Total knee arthroplasty implanted with standard guides . Experimental group: Total knee arthroplasty(TKA) implanted with GPS navigation system Patient (or their legal guardian) must provide/sign the informed consent prior to inclusion in the study.

After the surgery, patients will be followed-up at 6 weeks, 3, 6 and 12 months. At those times, data regarding physical and radiological examinations, pain and functionality and health status questionnaires will be collected.

Study Type

Interventional

Enrollment (Estimated)

158

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Madrid, Spain, 28009
    • Madrid
      • Majadahonda, Madrid, Spain, 28222
        • Recruiting
        • Hospital Universitario Puerta de Hierro Majadahonda
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Men and women over 18 years old.
  • Written informed consent according to ICH / GCP and Spanish legislation, obtained before any study procedure.
  • Patient with a BMI equal to or greater than 30 Kg / m2
  • Patients with clinical and radiological criteria of knee osteoarthritis.
  • Patients with indication for primary TKA according to medical criteria.

Exclusion Criteria:

  • Pregnancy or lactation.
  • Inability to give informed consent in the absence of a legal representative.
  • Subjects that are participating in a study with medicines or other medical devices.
  • Those who show inability to follow the instructions or collaborate during the development of the study.
  • If in the opinion of the researcher there are findings in the physical examination, abnormalities in the results of the clinical analyzes or other medical, social or psychosocial factors that could have a negative influence
  • Having had a previous surgical procedure on or around the knee in the last 12 months (such as proximal tibial osteotomy, femoral osteotomy, open reduction and internal fixation for a fracture, patellectomy or patellar realignment).
  • Need a simultaneous bilateral TKA.
  • Have a varus angle or valgus ≥ 15 °.
  • Total revision knee arthroplasty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Total knee arthroplasty implanted with GPS navigation system.
Obese patients undergoing Total Knee Arthroplasty, GPS achieved alignment
Active Comparator: Control
Total knee arthroplasty implanted with standard guides.
Obese patients undergoing Total Knee Arthroplasty, alignment achieved by using standard guides

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Deviation in a mechanical axis of knees
Time Frame: 12 months
Proportion of knees after surgery with a mechanical axis with a deviation greater than 3º
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiological axes (femoral)
Time Frame: 12 months
Position angle of the femoral component: angle formed between the anatomical axis of the femur and the articular surface of the femoral component of the TKA (α).
12 months
Radiological axes (tibial)
Time Frame: 12 months
Position angle of the tibial component: angle formed between the anatomical axis of the tibia and the proximal surface of the tibial component of the TKA (β).
12 months
Surgical procedure time
Time Frame: Week 1
Surgical time
Week 1
Admission (hospital) duration
Time Frame: Week 1
Number of days of the hospital admission
Week 1
Number of Surgical complications (Intraoperative)
Time Frame: Week 1
Intraoperative complications
Week 1
Number of Surgical complications (perioperative)
Time Frame: 1 to 6 weeks
perioperative complications
1 to 6 weeks
Number of Surgical complications (post-operative)
Time Frame: 1-12 months
postoperative complications
1-12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Society Score Questionaire
Time Frame: 6 weeks-12 months

KSS Questionaire, developed by the Knee Society, assesses the function of the knee replacement and the functional capabilities of patients after their implantation.

It has to separate sections ("Knee Score" and "Functional Score") that are scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.

6 weeks-12 months
Range of Motion
Time Frame: 6 weeks-12 months
The maximum extension and flexion
6 weeks-12 months
Visual Analogic Scale for pain
Time Frame: 1-12 months
VAS measure the intensity of the pain that the patient describes. It consists of a horizontal line of 10 centimeters, with 0cm being "no pain" and 10cm being "extreme pain".
1-12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pedro José Torrijos Garrido, MD, PhD, Hospital Universitario Puerta de Hierro

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 7, 2019

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

March 5, 2019

First Submitted That Met QC Criteria

March 5, 2019

First Posted (Actual)

March 7, 2019

Study Record Updates

Last Update Posted (Actual)

November 28, 2023

Last Update Submitted That Met QC Criteria

November 27, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Total knee arthroplasty implanted with GPS navigation system

Subscribe